LATEST MPNS CONTENT

Understanding the Importance of Transfusion Independence in MDS

Oncologists Choose Top Goals and Therapies for Treating MDS

Studies Explore Control of Thrombotic Events in High-Risk PV

Hematocrit Control, QOL Are Priorities in Low-Risk Polycythemia Vera

Optimizing Anemia Care with Targeted Therapies for Low-Risk MDS

Quality-of-Life Improvement Is Highly Valued in Polycythemia Vera

Starting Therapy for Intermediate-Risk Myelofibrosis Based on Hemoglobin

Ropeginterferon Alfa Shows Disease-Modifying Potential in Polycythemia Vera
CASE-BASED ROUNDTABLES
Advertisement
Advertisement






